SL-164
Encyclopedic
Encyclopedic
Typical encyclopedia coverage. Cross-reference for important decisions.
- 2 corroborating sources
- 2 ROAs with full dose ladders
- duration data present
- 17 combo interactions documented
- classified Research-chemical
- dose data not in PW/TripSit (unverifiable)
- 2 corroborating sources
- 2 ROAs with full dose ladders
- duration data present
- 17 combo interactions documented
- classified Research-chemical
- dose data not in PW/TripSit (unverifiable)
Aliases: Dcq
Summary
Case reports and user accounts highlight a pronounced tendency toward myoclonic twitching and seizures, especially above approximately 200 mg or when combined with other CNS depressants; emergency benzodiazepines are advised to manage convulsions. Illicit samples may contain residues of the synthesis precursor 4-chloro-o-toluidine, which can cause methemoglobinemia and hematuria. Users report effects similar to GHB and carisoprodol with notable euphoria and muscle relaxation, but seizure risk limits therapeutic potential.
Dose Information
Dose basis. Dose bands are compiled from user reports and forum accounts, not clinical data; individual sensitivity varies widely. Start with an allergy test (1β2 mg) and use a calibrated milligram scale; consider volumetric dosing for accuracy. Redosing within 2 hours increases risk because of delayed onset and stacking. Evidence base: community reports and general HR guidance. Reports describe marked nasal irritation (βburning/like chlorineβ), inconsistent absorption, and more abrupt adverse effects (tremor/jerks). Insufflation is discouraged for this compound. Evidence base: user reports. (Dose figures and this note are from Drugs.Wiki.)
| ROA | Light | Common | Strong | Heavy |
|---|---|---|---|---|
| Oral | 50-100mg | 100-250mg | 250-400mg | 400mg+ |
| Insufflated | 30-60mg | 60-120mg | 120-200mg | 200mg+ |
Onset, Duration & After-effects
| ROA | Onset | Comeup | Peak | Offset | Total |
|---|---|---|---|---|---|
| Oral | 30-60 min | 15-30 min | 45 min | 1-2 hrs | 2.5-4.25 hrs |
| Insufflated | 15-30 min | 10-20 min | 30 min | 1-2 hrs | 1.92-3.33 hrs |
Effect Profile
Scores (1–10) curated from multiple sources:
- Effect keyword matching from PsychonautWiki catalog
- Weighted by importance: core (×3), major (×2), minor (×1)
Strong anxiolysis, cognitive impairment, and euphoria with mild sedation
Add to PsychonautWiki Journal
The PsychonautWiki Journal logging app doesn't include every substance. To track SL-164 there, start adding an ingestion, search for the name, and choose to add it as a custom substance. Paste these values:
SL-164 Source: SubstanceSearch (substancesearch.com) Oral dose (mg): threshold 30 Β· light 50-100 Β· common 100-250 Β· strong 250-400 Β· heavy 400+ Insufflated dose (mg): threshold 20 Β· light 30-60 Β· common 60-120 Β· strong 120-200 Β· heavy 200+ Oral duration: onset 0.5-1h Β· come-up 15-30m Β· peak 45m Β· offset 1-2h Β· total 2.5-4.25h Β· after-effects 2-8h Insufflated duration: onset 15-30m Β· come-up 10-20m Β· peak 30m Β· offset 1-2h Β· total 1.92-3.33h Β· after-effects 2-8h Note: ranges are harm-reduction guidance, not a prescription. Start low, go slow, and test your substances.
Tip: for quicker logging you can also add a Custom Unit in the app, e.g. common dose ~ 175 mg (Oral).
The app keeps custom substances simple, so the full dose ranges live in the description text above. Ranges are harm-reduction guidance, not a prescription.
Tolerance
Tolerance Decay
Acute tolerance: develops within a single session β the reset numbers above apply after sustained heavy use, not after one binge. Within-session tachyphylaxis usually resets largely overnight.
Patterns inferred from sedative-hypnotic class (methaqualone/benzodiazepines) and anecdotal reports of rapid tolerance; figures are heuristic and low confidence. Space uses by multiple days to reduce risk.
Cross-Tolerances
Effects
- Physical euphoria
- Anxiolysis
- Muscle relaxation
- Anxiolytic
- Ataxia
- Myoclonic twitching
- Seizures
- Respiratory depression
- Sedation
- Sedative
- Euphoria
- Anxiety suppression
- Dream potentiation
- Cognitive euphoria
- Motor control loss
- Dizziness
- Amnesia
- Memory suppression
- Delirium
- Thought deceleration
- Tactile enhancement
- Increased libido
- Disinhibition
- Acuity suppression
- Double vision
- Dulled perception
- Visual disconnection
- Internal hallucination
- Changes in gravity
- Internal hallucinations
Combinations
Cross-Check SL-164 with another substanceHelpful Links
Report an issue or suggest an edit
Spotted incorrect or dangerous information, have a correction, a new study, or a useful addition for SL-164? Let us know. Reports are reviewed by moderators — this is not posted publicly.